Sarafloxacin-d8 (hydrochloride trihydrate)

Sarafloxacin-d8 (hydrochloride trihydrate) is the deuterium labeled Sarafloxacin hydrochloride trihydrate. Sarafloxacin hydrochloride trihydrate is a quinolone antibiotic compound[1][2].

Product Specifications

Product Name Alternative

A-56620-d8 (hydrochloride trihydrate)

UNSPSC

12352005

Target

Bacterial

Type

Isotope-Labeled Compounds

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Solubility

10 mM in DMSO

Smiles

O=C(C1=CN(C2=CC=C(F)C=C2)C3=C(C=C(F)C(N4C([2H])([2H])C([2H])([2H])NC([2H])([2H])C4([2H])[2H])=C3)C1=O)O.Cl.O.O.O

Molecular Formula

C20H16D8ClF2N3O6

Molecular Weight

483.92

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]McConville, M.L., et al., Effects of sarafloxacin hydrochloride on human enteric bacteria under simulated human gut conditions. Vet Q, 1995. 17 (1) : p. 1-5.